Leukemia Clinical Trials in Boston

Showing 981-1000 of 1,243 trials

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

NCT01534715

The purpose of this study is to test the safety and tolerability of IMGN529 in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL).

Lymphoma, Non-HodgkinChronic Lymphocytic Leukemia

ImmunoGen, Inc.49 participantsStarted Jan 2012

Boston, Massachusetts, United States • New York, New York, United States • Columbus, Ohio, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

NCT00334893

This phase II trial is studying how well eribulin mesylate works in treating patients with recurrent ovarian epithelial, primary peritoneal cavity, or fallopian tube cancer. Drugs used in chemotherapy, such as eribulin mesylate, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer

National Cancer Institute (NCI)74 participantsStarted Apr 2006

Boston, Massachusetts, United States • New York, New York, United States

COMPLETEDPhase 2< 1 mile

The Effect of Thiamine vs. Placebo on VO2 in Critical Illness

NCT01985685

The objective of this study is to determine the effect of thiamine therapy on oxygen consumption (VO2) in critically-ill patients. We will evaluate this by measuring VO2 before and after thiamine or placebo administration in patients admitted to the ICU and requiring mechanical ventilation. A secondary aim is to evaluate the effect of thiamine vs. placebo on the metabolic profile of the patients.

Critically IllRespiratory Failure

Beth Israel Deaconess Medical Center66 participantsStarted Oct 2013

Boston, Massachusetts, United States

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

The Effect of Thiamine vs. Placebo on VO2 in Critical Illness

Leukemia Trials in Other Cities

Physiologic Definition of Bronchopulmonary Dysplasia

T Cell Effector and Regulatory Mechanisms in Asthma

Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants

Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Delayed Cord Clamping in VLBW Infants

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Emerging Adults Who Use Alcohol and Marijuana

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Other Conditions in Boston